Latest Growth factors Stories
RARITAN, N.J. and SAN ANTONIO, Dec.
ResearchMoz.us include new market research report " China Recombinant Protein Drug Industry, 2014-2017: Market Size, Shares, Growth, Analysis, Trends And Forecast" to its huge collection
Surveyed European Oncologists Expect to Use Future Biosimilar G-CSFs in a Greater Proportion of Eligible Patients than Biosimilar MAbs, According to Findings from Decision Resources Group BURLINGTON,
RnRMarketResearch.com adds "Hematopoietic Stem Cell Transplantation – Pipeline Review, H2 2014" to its store.
CYRAMZA now approved both as a single-agent treatment and in combination with chemotherapy INDIANAPOLIS, Nov.
Nutronics Labs remains the only Deer Antler Spray manufacturer to have studies conducted on their own products RENO, Nev., Oct.
AllMed webinar provides in-depth review of the latest standard of care for the use of ESAs in the treatment of Chronic Kidney Disease. Portland, OR (PRWEB) August
THOUSAND OAKS, Calif., Aug.
-Primary efficacy results on track to be received by end of August 2014 TOORAK, Australia, July 29, 2014 /PRNewswire/ -- Antisense Therapeutics Limited ("ANP") is pleased to report
- A member of the swell-mob; a genteelly clad pickpocket. Sometimes mobsman.